Cargando…

Long non-coding RNA MIDEAS-AS1 inhibits growth and metastasis of triple-negative breast cancer via transcriptionally activating NCALD

BACKGROUND: Triple-negative breast cancer (TNBC) is a subtype of breast cancer with higher aggressiveness and poorer outcomes. Recently, long non-coding RNAs (lncRNAs) have become the crucial gene regulators in the progression of human cancers. However, the function and underlying mechanisms of lncR...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Dan, Liang, Yiran, Wang, Yajie, Ye, Fangzhou, Jin, Yuhan, Li, Yaming, Han, Dianwen, Wang, Zekun, Chen, Bing, Zhao, Wenjing, Wang, Lijuan, Chen, Xi, Jiang, Liyu, Yang, Qifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540452/
https://www.ncbi.nlm.nih.gov/pubmed/37770991
http://dx.doi.org/10.1186/s13058-023-01709-1
_version_ 1785113722615758848
author Luo, Dan
Liang, Yiran
Wang, Yajie
Ye, Fangzhou
Jin, Yuhan
Li, Yaming
Han, Dianwen
Wang, Zekun
Chen, Bing
Zhao, Wenjing
Wang, Lijuan
Chen, Xi
Jiang, Liyu
Yang, Qifeng
author_facet Luo, Dan
Liang, Yiran
Wang, Yajie
Ye, Fangzhou
Jin, Yuhan
Li, Yaming
Han, Dianwen
Wang, Zekun
Chen, Bing
Zhao, Wenjing
Wang, Lijuan
Chen, Xi
Jiang, Liyu
Yang, Qifeng
author_sort Luo, Dan
collection PubMed
description BACKGROUND: Triple-negative breast cancer (TNBC) is a subtype of breast cancer with higher aggressiveness and poorer outcomes. Recently, long non-coding RNAs (lncRNAs) have become the crucial gene regulators in the progression of human cancers. However, the function and underlying mechanisms of lncRNAs in TNBC remains unclear. METHODS: Based on public databases and bioinformatics analyses, the low expression of lncRNA MIDEAS-AS1 in breast cancer tissues was detected and further validated in a cohort of TNBC tissues. The effects of MIDEAS-AS1 on proliferation, migration, invasion were determined by in vitro and in vivo experiments. RNA pull-down assay and RNA immunoprecipitation (RIP) assay were carried out to reveal the interaction between MIDEAS-AS1 and MATR3. Luciferase reporter assay, Chromatin immunoprecipitation (ChIP) and qRT-PCR were used to evaluate the regulatory effect of MIDEAS-AS1/MATR3 complex on NCALD. RESULTS: LncRNA MIDEAS-AS1 was significantly downregulated in TNBC, which was correlated with poor overall survival (OS) and progression-free survival (PFS) in TNBC patients. MIDEAS-AS1 overexpression remarkably inhibited tumor growth and metastasis in vitro and in vivo. Mechanistically, MIDEAS-AS1 mainly located in the nucleus and interacted with the nuclear protein MATR3. Meanwhile, NCALD was selected as the downstream target, which was transcriptionally regulated by MIDEAS-AS1/MATR3 complex and further inactivated NF-κB signaling pathway. Furthermore, rescue experiment showed that the suppression of cell malignant phenotype caused by MIDEAS-AS1 overexpression could be reversed by inhibition of NCALD. CONCLUSIONS: Collectively, our results demonstrate that MIDEAS-AS1 serves as a tumor-suppressor in TNBC through modulating MATR3/NCALD axis, and MIDEAS-AS1 may function as a prognostic biomarker for TNBC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13058-023-01709-1.
format Online
Article
Text
id pubmed-10540452
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105404522023-09-30 Long non-coding RNA MIDEAS-AS1 inhibits growth and metastasis of triple-negative breast cancer via transcriptionally activating NCALD Luo, Dan Liang, Yiran Wang, Yajie Ye, Fangzhou Jin, Yuhan Li, Yaming Han, Dianwen Wang, Zekun Chen, Bing Zhao, Wenjing Wang, Lijuan Chen, Xi Jiang, Liyu Yang, Qifeng Breast Cancer Res Research BACKGROUND: Triple-negative breast cancer (TNBC) is a subtype of breast cancer with higher aggressiveness and poorer outcomes. Recently, long non-coding RNAs (lncRNAs) have become the crucial gene regulators in the progression of human cancers. However, the function and underlying mechanisms of lncRNAs in TNBC remains unclear. METHODS: Based on public databases and bioinformatics analyses, the low expression of lncRNA MIDEAS-AS1 in breast cancer tissues was detected and further validated in a cohort of TNBC tissues. The effects of MIDEAS-AS1 on proliferation, migration, invasion were determined by in vitro and in vivo experiments. RNA pull-down assay and RNA immunoprecipitation (RIP) assay were carried out to reveal the interaction between MIDEAS-AS1 and MATR3. Luciferase reporter assay, Chromatin immunoprecipitation (ChIP) and qRT-PCR were used to evaluate the regulatory effect of MIDEAS-AS1/MATR3 complex on NCALD. RESULTS: LncRNA MIDEAS-AS1 was significantly downregulated in TNBC, which was correlated with poor overall survival (OS) and progression-free survival (PFS) in TNBC patients. MIDEAS-AS1 overexpression remarkably inhibited tumor growth and metastasis in vitro and in vivo. Mechanistically, MIDEAS-AS1 mainly located in the nucleus and interacted with the nuclear protein MATR3. Meanwhile, NCALD was selected as the downstream target, which was transcriptionally regulated by MIDEAS-AS1/MATR3 complex and further inactivated NF-κB signaling pathway. Furthermore, rescue experiment showed that the suppression of cell malignant phenotype caused by MIDEAS-AS1 overexpression could be reversed by inhibition of NCALD. CONCLUSIONS: Collectively, our results demonstrate that MIDEAS-AS1 serves as a tumor-suppressor in TNBC through modulating MATR3/NCALD axis, and MIDEAS-AS1 may function as a prognostic biomarker for TNBC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13058-023-01709-1. BioMed Central 2023-09-28 2023 /pmc/articles/PMC10540452/ /pubmed/37770991 http://dx.doi.org/10.1186/s13058-023-01709-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Luo, Dan
Liang, Yiran
Wang, Yajie
Ye, Fangzhou
Jin, Yuhan
Li, Yaming
Han, Dianwen
Wang, Zekun
Chen, Bing
Zhao, Wenjing
Wang, Lijuan
Chen, Xi
Jiang, Liyu
Yang, Qifeng
Long non-coding RNA MIDEAS-AS1 inhibits growth and metastasis of triple-negative breast cancer via transcriptionally activating NCALD
title Long non-coding RNA MIDEAS-AS1 inhibits growth and metastasis of triple-negative breast cancer via transcriptionally activating NCALD
title_full Long non-coding RNA MIDEAS-AS1 inhibits growth and metastasis of triple-negative breast cancer via transcriptionally activating NCALD
title_fullStr Long non-coding RNA MIDEAS-AS1 inhibits growth and metastasis of triple-negative breast cancer via transcriptionally activating NCALD
title_full_unstemmed Long non-coding RNA MIDEAS-AS1 inhibits growth and metastasis of triple-negative breast cancer via transcriptionally activating NCALD
title_short Long non-coding RNA MIDEAS-AS1 inhibits growth and metastasis of triple-negative breast cancer via transcriptionally activating NCALD
title_sort long non-coding rna mideas-as1 inhibits growth and metastasis of triple-negative breast cancer via transcriptionally activating ncald
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540452/
https://www.ncbi.nlm.nih.gov/pubmed/37770991
http://dx.doi.org/10.1186/s13058-023-01709-1
work_keys_str_mv AT luodan longnoncodingrnamideasas1inhibitsgrowthandmetastasisoftriplenegativebreastcancerviatranscriptionallyactivatingncald
AT liangyiran longnoncodingrnamideasas1inhibitsgrowthandmetastasisoftriplenegativebreastcancerviatranscriptionallyactivatingncald
AT wangyajie longnoncodingrnamideasas1inhibitsgrowthandmetastasisoftriplenegativebreastcancerviatranscriptionallyactivatingncald
AT yefangzhou longnoncodingrnamideasas1inhibitsgrowthandmetastasisoftriplenegativebreastcancerviatranscriptionallyactivatingncald
AT jinyuhan longnoncodingrnamideasas1inhibitsgrowthandmetastasisoftriplenegativebreastcancerviatranscriptionallyactivatingncald
AT liyaming longnoncodingrnamideasas1inhibitsgrowthandmetastasisoftriplenegativebreastcancerviatranscriptionallyactivatingncald
AT handianwen longnoncodingrnamideasas1inhibitsgrowthandmetastasisoftriplenegativebreastcancerviatranscriptionallyactivatingncald
AT wangzekun longnoncodingrnamideasas1inhibitsgrowthandmetastasisoftriplenegativebreastcancerviatranscriptionallyactivatingncald
AT chenbing longnoncodingrnamideasas1inhibitsgrowthandmetastasisoftriplenegativebreastcancerviatranscriptionallyactivatingncald
AT zhaowenjing longnoncodingrnamideasas1inhibitsgrowthandmetastasisoftriplenegativebreastcancerviatranscriptionallyactivatingncald
AT wanglijuan longnoncodingrnamideasas1inhibitsgrowthandmetastasisoftriplenegativebreastcancerviatranscriptionallyactivatingncald
AT chenxi longnoncodingrnamideasas1inhibitsgrowthandmetastasisoftriplenegativebreastcancerviatranscriptionallyactivatingncald
AT jiangliyu longnoncodingrnamideasas1inhibitsgrowthandmetastasisoftriplenegativebreastcancerviatranscriptionallyactivatingncald
AT yangqifeng longnoncodingrnamideasas1inhibitsgrowthandmetastasisoftriplenegativebreastcancerviatranscriptionallyactivatingncald